Trevin Rard News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19Labcorp Using PacBio s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U S
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Pacific Biosciences Grants Equity Incentive Award to New Employee
Pacific Biosciences of California, Inc.January 29, 2021 GMT
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 110,000 shares of Pacific Biosciences common stock and restricted stock units (“RSU”) covering 55,000 shares of Pacific Biosciences common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan on December 14, 2020 (the “2020 Inducement Plan”).
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Pacific Biosciences Grants Equity Incentive Awards to New Employees
Pacific Biosciences of California, Inc.January 12, 2021 GMT
MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock units (“RSUs”) covering 335,000 shares of Pacific Biosciences common stock to the Company’s recently hired Chief Operating Officer, Mark Van Oene, under the Pacific Biosciences 2020 Inducement Equity Incentive Plan (the “Inducement Plan”) effective on January 8, 2021.
Pacific Biosciences of California, Inc. Announces Preliminary Fourth Quarter 2020 Revenue
Pacific Biosciences of California, Inc. Announces Preliminary Fourth Quarter 2020 Revenue
MENLO PARK, Calif., Jan. 11, 2021 Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing platforms, today announced unaudited preliminary revenue of approximately $27 million for its fourth quarter ended December 31, 2020. The Company’s full financial results for the fourth quarter and the fiscal year ended December 31, 2020 are not yet available.
Financial and Operational Highlights
Preliminary fourth quarter revenue is expected to be approximately $27 million, representing an estimated increase of approximately 41% sequentially compared with $19.1 million for the third quarter of 2020.
vimarsana © 2020. All Rights Reserved.